Search

everythinglearnresearchcommunity

for

Search:↓

Children with alopecia areata, especially with Down syndrome or thyroid issues, should be screened for thyroid disease.

Blocking specific proteins can help remove aging cells and might treat age-related diseases and promote hair growth.

Glibenclamide slows breast cancer cell growth by stopping cell division.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Acute leukemias with the Philadelphia chromosome may be biphenotypic, and identifying this is important for proper treatment.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

miR-122 causes hair loss by killing hair cells.

A new one-step test can quickly identify skin cancer during surgery.

Basonuclin helps identify and track hair follicle development and cycling in mice.

DAB labeling effectively identifies collagen type III and PDGFR in horse skin, but may show false positives.

Four antibodies were developed to help study hair follicle cell differentiation.

Basal cell epithelioma-like changes are most similar to normal basal cells.

The document doesn't provide a clear conclusion or detailed findings about the impact of certain cells on cancer treatment.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

CYLD deficiency in skin tumors disrupts hair follicle cell processes and protein secretion.

GLI1 RNA CISH effectively identifies basal cell carcinoma but is less specific for benign follicular tumors.

TCDD changes skin cell growth and keratin production in mice.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

Increased methylation of the Filip1l gene may contribute to aggressive skin cancer.

Basal cell carcinomas have much higher levels of Vitamin D3 receptors compared to healthy skin.

The assay effectively identifies compounds that affect immune cell activation.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Overexpressing 14-3-3σ in mice skin reduces cell growth and hair density.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

AI can help diagnose Follicular Lymphoma by accurately identifying specific cell types.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.